| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 10/23/2026 | ±3.4% | +5.2% | under-priced |
| 07/24/2026 | ±4.0% | +2.0% | over-priced |
| 04/24/2026 | ±4.5% | +1.8% | over-priced |
| 02/06/2026 | ±3.4% | +3.4% | under-priced |
| 10/24/2025 | ±5.0% | -2.5% | over-priced |
| 07/25/2025 | ±3.7% | +0.1% | over-priced |
| 04/25/2025 | ±6.0% | -1.7% | over-priced |
| 02/12/2025 | ±3.0% | -2.0% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $0.50 | $5.7B | $417M |
| Q2 FY2026 | $0.64 | $5.7B | $534M |
| Q1 FY2026 | $0.55 | $5.4B | $461M |
| Q4 FY2025 | — | $5.7B | $589M |
Halliburton Company (HAL) reports in 86 days, with the next report estimated for 01/22/2027. Across the last 8 reports, options priced an average ±4.1% earnings move while the stock actually moved 2.3% on average — the market has systematically over-priced HAL's earnings risk. Fundamentals into the print: EPS up 2400.0% year-over-year, revenue up 1.8%. QuantLogix's live 5-factor engine currently reads HAL as a buy at 58/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →